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Background. This study was performed to characterize the epidemiology, management, and outcomes of skin and soft tissue 
infection (SSTI) and colonization due to carbapenem-resistant Enterobacteriaceae (CRE).
Methods. Patients from the Consortium on Resistance Against Carbapenem in Klebsiella and Other Enterobacteriaceae 
(CRACKLE-1) from December 24, 2011 to October 1, 2014 with wound cultures positive for CRE were included in the study. 
Predictors of surgical intervention were analyzed. Molecular typing of isolates was performed using repetitive extragenic palindro-
mic polymerase chain reaction (PCR). Carbapenemase genes were detected using PCR.
Results. One hundred forty-two patients were included: 62 had SSTI (44%) and 56% were colonized. Mean age was 61 years, and 
48% were male: median Charlson score was 3 (interquartile range, 1–5). Forty-eight percent of patients were admitted from long-
term care facilities (LTCFs), and 31% were from the community. Two strain types (ST258A and ST258B) were identified (73% of 45 
tested). Carbapenemase genes were detected in 40 of 45 isolates (blaKPC-3 [47%], blaKPC-2 [42%]). Sixty-eight patients (48%) underwent 
surgical intervention, 63% of whom had SSTI. Patients admitted from LTCFs were less likely to undergo surgical intervention (odds 
ratio [OR], 0.36; 95% confidence interval [CI], 0.18–0.71). In multivariable analysis, among patients with SSTI, those admitted from 
LTCFs were less likely to undergo debridement (OR, 0.18; 95% CI, 0.04–0.93).
Conclusions. Patients admitted from LTCFs with CRE SSTI were less likely to undergo surgical intervention. Sixteen percent of 
the patients died, and approximately 50% of survivors required more intensive care upon discharge. These findings suggest a unique, 
impactful syndrome within the CRE infection spectrum. Further studies are needed to assess the role of surgical debridement in 
management of CRE-SSTI, particularly among LTCF residents.
Keywords. carbapenem-resistant Enterobacteriaceae; Klebsiella pneumoniae; ST258; surgical site infections; wound infection. 
The management of wounds may be associated with acquisi-
tion or emergence of resistance among bacteria that infect or 
colonize these wounds [1–3]. Often, chronic wounds occur in 
patients who are already at increased risk for carriage of mul-
tidrug-resistant organisms (MDROs), due to the presence of 
comorbid conditions as well as frequent exposures to healthcare 
systems and antimicrobials [1]. Furthermore, chronic wounds 
can foster the emergence and persistence of MDROs due to 
poor vascular supply and biofilm production, which limits the 
ability of antimicrobials to achieve therapeutic concentrations 
within the wound microbiome [3–5].
Carbapenem-resistant Enterobacteriaceae (CRE) are recog-
nized by the US Centers for Diseases Control and Prevention 
(CDC) to be an urgent public health threat [6]. Carbapenem-
resistant Enterobacteriaceae are reported to be important path-
ogens in wound infection in several regions including in the 
Middle East, Asia, and South and North America [7–10]. In 
addition to fostering the growth of bacteria and emergence of 
resistance, bacterial wound infection itself impedes the heal-
ing process [2, 11]. Given the limited antimicrobial options for 
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treatment of CRE, wound infections caused by CRE may be 
particularly challenging to manage.
Surgical debridement has an important role in the thera-
peutic management of infected wounds. Debridement involves 
removing necrotic tissue and improving vascular supply, as 
well as lowering the burden of pathogens and their associated 
biofilm [12]. Wound debridement has been shown to improve 
wound healing [1, 12–15], and it might be particularly crucial 
for the treatment of soft tissue infections (SSTIs) due to CRE, 
where medical treatment options are limited. To date, the 
impact of surgical intervention is not yet described in patients 
with complex SSTIs due to CRE.
The objectives of this study were to characterize the epide-
miology and management of patients with SSTI and/or colo-
nization due to CRE in a US clinical consortium. In addition, 
predictors of outcome, surgical intervention, and debridement 
were assessed. Our analyses in this chronically ill and debili-
tated population uncovered unexpected findings regarding sur-
gical interventions and outcomes.
METHODS
Study Design, Setting, and Variables
The Consortium on Resistance Against Carbapenem in Klebsiella 
pneumoniae and Other Enterobacteriaceae (CRACKLE) is a 
prospective multicenter consortium that includes the partic-
ipation of 18 hospitals that are part of 8 healthcare systems 
predominantly located in the Great Lakes region of the United 
States [16]. Initially, the consortium included patients with only 
carbapenem-resistant K pneumoniae (CRKP). Since October 
2014, other CRE species were also included.
This study evaluated a nested cohort within the CRACKLE-1 
consortium cohort. All hospitalized patients between December 
2011 and February 2016 who had skin or soft tissue (wound) 
cultures growing CRE were included. Each patient was included 
once at the time of their first CRE-positive wound culture. 
Patients were evaluated for the presence of SSTI. One type of 
SSTI was surgical site infection (SSI). Cultures derived from 
surgical wounds were defined as a SSI when they met CDC/
National Healthcare Safety Network criteria [17]. The other type 
of SSTI was infection present in nonsurgical wounds, which was 
determined to be present when there was a positive wound cul-
ture, documentation of infection by the treating physician, as 
well as an evidence of inflammation on the day of positive cul-
ture (defined as an abnormal white blood cell count [>10 000 or 
<4000 cells/µL] and/or abnormal body temperature [>99.5°F or 
<96°F]). Surgical and nonsurgical wound cultures that did not 
meet criteria for infection were categorized as colonizers.
Data pertaining to patients’ demographics and comorbid 
conditions, including Charlson’s score index [18], admission 
source, discharge disposition, as well as antimicrobial treat-
ment, antimicrobial susceptibilities of CRE, Pitt bacteremia 
score at the day of positive culture (which has been previously 
been validated as a predictor of mortality in patients with CRKP 
infections) [16, 19, 20], and surgical interventions were pro-
spectively collected. Number of effective antimicrobial agents 
administered was captured. Ceftazidime-avibactam, tigecy-
cline, and colistin were assumed to be effective when in vitro 
susceptibility was not available. Long-term care facility (LTCF) 
included both long-term acute care (LTAC) and skilled nursing 
home (SNF). Clinical outcomes that were collected included 
in-hospital mortality, duration of hospitalization, and discharge 
disposition categorized as “worsened”. Worsened discharge dis-
position was defined as surviving patients who were discharged 
to a location that was associated with requiring “more intensive 
care” compared with their admission source (eg, home to an 
LTCF, home to other hospital, LTCF to hospital, SNF to LTAC). 
The Institutional Review Boards of all of the healthcare systems 
involved approved this study.
Microbiology
Carbapenem-resistant Enterobacteriaceae was defined, accord-
ing to the Clinical and Laboratory Standard Institute (CLSI) 
guidelines [21], as Enterobacteriaceae resistant to 1 or more of 
the following carbapenems: imipenem, meropenem, or ertape-
nem. Bacterial identification and routine antimicrobial suscep-
tibilities were performed using MicroScan (Siemens Healthcare 
Diagnostics) or Vitek 2 (bioMérieux) supplemented by a GN4F 
Sensititre tray (Thermo Fisher Scientific) to confirm carbape-
nem susceptibility results.
Detection of Carbapenemase Genes in Carbapenem-Resistant 
Enterobacteriaceae and Strain Typing
Carbapenem-resistant Enterobacteriaceae-associated carbap-
enemase genes were detected by polymerase chain reaction 
(PCR) amplification of blaKPC, blaNDM, blaVIM, blaIMP, and blaOXA-48 
genes using established primers as previously described [22]. 
For molecular typing of CRE, repetitive extragenic palindro-
mic PCR (rep-PCR) were used to identify similarities among 
isolates. In brief, rep-PCR was conducted using the DiversiLab 
strain typing system (Bacterial BarCodes; bioMérieux, Athens, 
GA) isolates. Similarity of 95% or greater were considered to be 
of the same rep-PCR type [23, 24]. Multilocus sequence typing 
was performed on CRKP isolates from the predominant rep-
PCR types, as previously described [25].
Data Analysis
Risk Factor Analysis.
Risk factor analyses were conducted, including comparing 
patients who underwent surgical intervention with patients who 
did not require surgical intervention during the study period, 
using the Wilcoxon rank-sum test or Student’s t test for contin-
uous variables and Fisher’s exact test or χ2 test for dichotomous 
and nominal variables. Correlation coefficients were deter-
mined using the Pearson correlation coefficient. Multivariable 
risk factor analyses were performed using logistic regression, to 
identify predictors of surgical intervention.
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To assess the independent effect of admission from an LTCF 
on the likelihood of undergoing surgical intervention, a pro-
pensity score predicting the likelihood of admission from an 
LTCF was computed by comparing patients admitted from 
LTCFs with those not admitted from LTCFs. A  multivariable 
logistic regression was built, and a propensity score was devel-
oped by summing together the β-coefficients of variables in 
the model. To determine the independent impact of admission 
from an LTCF on surgical intervention, a multivariable logistic 
regression model predicting the likelihood of surgical interven-
tion was constructed, and the propensity score and admission 
from an LTCF were analyzed as independent variables.
Outcomes Analysis.
Bivariable outcomes analyses were performed to evaluate 
the impact of surgical intervention on in-hospital mortality 
and worsened disposition using the statistical tests described 
above. For the latter outcome, only patients who survived were 
included in the analysis. In addition, predictors of in-hospital 
mortality were assessed, and associations between SSTI and 
outcomes (compared with colonization) were assessed in bivar-
iable analysis.
Multivariable Modeling
For all multivariate analyses, variables with P < .2 in bivariable 
analysis were evaluated for inclusion in multivariable models. 
The final models included variables with P < .05. Confounding 
variables were defined as variables that changed the β-coeffi-
cient of one of the variables in the final model by 10% or more. 
Variables were evaluated for confounding and, if identified as 
confounders, were retained in the final model, regardless of their 
P value. Multivariable analyses of in-hospital mortality and wors-
ened disposition were performed using logistic regression; mul-
tivariable analysis of duration of hospitalization was performed 
using linear regression, after log transformation of this outcome 
variable. For multivariable predictors of log duration of hospitali-
zation, the inverse natural log of the β-coefficients was calculated 
for variables in the final regression model and was referred to as 
the multiplicative effect (ME) [26]. P < .05 was considered to be 
statistically significant, and all P values were 2-sided.
RESULTS
Overall Cohort Description
One hundred forty-two patients were identified with positive 
soft tissue cultures for CRE (Table 1), 138 (97%) of which were 
CRKP, 3 were carbapenem-resistant (CR) Enterobacter spp, and 1 
was CR Citrobacter spp. Sixty-two (44%) patients met criteria for 
a diagnosis of SSTI and 80 (56%) were colonized. Characteristics 
of colonized and infected patients were similar, except that sig-
nificantly more infected patients had postsurgical wounds than 
did colonized patients (41.9% and 21.3%, respectively; P = .01) 
(Supplementary Table  1), and that surgical intervention was 
more common in infected patients (see below). The mean age 
of patients was 61 years (±17 years), 48% were male, and 56% 
were white. The median Charlson’s score was 3 (range, 0–9). 
Diabetes mellitus was documented in 55% of patients. Seventy-
nine (56%) patients were admitted from an LTCF.
The most common wound type was a pressure ulcer (34%) 
followed by postoperative wound infection (SSI; 30%). Wounds 
were mostly located in the extremities (27%) followed by the 
sacrum (24%). The majority of cultures were poly-microbial 
(66%), and 44 (31%) patients had CRE from other sources, 
including urine, blood, and respiratory tract. Most of patients 
received antimicrobial treatment (73.9%), and approximately 
half of the subjects were treated with at least 1 antibiotic with 
in vitro efficacy. No significant differences in antibiotic treat-
ment between colonized and infected patients were observed 
(Supplementary Table 1). The median duration of hospitaliza-
tion was 2 days (0–9), 22 patients (15.5%) died in-hospital, and 
41 (29%) had worsened discharge disposition.
Of the 142 cultures, 45 CRE isolates were available for molec-
ular strain typing as well as carbapenemase gene determination. 
Carbapenemase genes were detected in 40 isolates, 21 (47%) of 
which had blaKPC-3, and 19 (42%) had blaKPC-2. Among K. pneumo-
niae isolates carrying blaKPC, the 2 predominant strain types were 
ST258B and ST258A (18 [40%] and 15 [33%], respectively) [16, 22].
Surgical Intervention
Surgical debridement was performed in 68 patients (48%), 
half of whom (n = 34) underwent debridement in the operat-
ing room (Table 1). Forty-three of 62 infected patients (69.3%) 
underwent surgical debridement of the wound in comparison 
to 25 of 80 (31.2%) colonized patients (P < .001).
Predictors of surgical intervention in the bivariable anal-
ysis are presented in Tables 1 and 2. In multivariable analy-
sis (Table  3), independent predictors of surgical intervention 
included presence of SSI (odds ratio [OR], 9.60; 95% confi-
dence interval [CI], 2.85–32.39) as well as SSTI without SSI 
(OR, 2.72; 95% CI, 1.13–6.53) (reference group for both was 
subjects without infection). Undergoing surgical intervention is 
less likely for those admitted from LTCF than those admitted 
from other sources (OR, 0.36; 95% CI, 0.18–0.71). This model 
was controlled for the confounding effects of isolating CRE 
from extremity wounds. In a subgroup analysis including only 
patients with SSTI (n = 62), admission from an LTCF remained 
associated with a decreased likelihood to undergo surgical 
debridement (OR, 0.18; 95% CI, 0.04–0.93).
Propensity-Adjusted Analysis of the Association Between Admission 
From a Long-Term Care Facility and Surgical Intervention
To further explore the association between admission from an 
LTCF and surgical intervention in the entire cohort, a propen-
sity score was developed predicting the probability of being 
admitted from an LTCF. Variables associated with admission 
from an LTCF that were included in the propensity score 
4 • OFID • Henig et al
included Charlson’s score greater than 2, pressure ulcer wound 
type, polymicrobial culture, immunosuppression, and presence 
of SSI. In multivariable analysis controlling for the effects of 
propensity score, admission from an LTCF was no longer sig-
nificantly associated with a decreased likelihood of undergoing 
surgical intervention (OR, 0.49; 95% CI, 0.22–1.11; P = .09).
Outcomes and Surgical Intervention
Mortality and Worsened Discharge Disposition
Twenty-two (15.5%) patients died during hospitalization, and 
41 patients (34% of those subjects who survived) required 
higher level of supportive care when they were discharged, 
compared with the care they required before admission.
In bivariable analysis, predictors of in hospital mortality 
included immunosuppression (OR, 8.38; 95% CI, 2.82–24.90), 
Pitt score greater than 3 (OR, 8.18; 95% CI, 2.93–22.87), and 
prolonged duration of hospitalization before the first posi-
tive culture (median durations of 1  day, interquartile range 
[IQR] = 0–7 for survivors, and 15 days, IQR = 2–41 for those 
who died; P < .0001). Patients who were admitted from an LCTF 
were less likely to die (OR, 0.30; 95% CI, 0.11–0.80).
Associations between surgical intervention and in-hospi-
tal mortality and between surgical intervention and worsened 
disposition at discharge in were not observed (OR = 1.14, 95% 
CI, 0.46–2.85 and OR = 0.73, 95% CI, 0.34–1.56, respectively 
in bivariable analyses). In a subgroup analysis of patients with 
SSTI (N  =  62), surgical intervention was not associated with 
in-hospital mortality (OR, 1.05; 95% CI, 0.28–3.28).
Duration of Hospitalization
 The median duration of hospitalization for the subjects 
in the cohort was 13  days (6.75–25.25). In bivariable analy-
sis, surgical intervention was associated with an increased 
duration of hospitalization (P =  .025). In multivariable anal-
ysis, the impact of surgical intervention was evaluated, after 
controlling for the differences between those patients who 
underwent surgical debridement and those who did not (ie, 
controlled for admission from LTCF, Pitt score, wound loca-
tion, wound type, and SSTI). Surgical intervention was not 
significantly associated with duration of hospitalization (ME, 
1.1; 95% CI, 0.80–1.52).










N = 74 OR (95% CI) P Value
Demographics
Age (mean ± SD) 68.3 ± 17.1 59.5 ± 17.3 62.9 ± 16.8 .24
Female 74 (52) 38 (55.9) 36 (48.6) 1.34 (0.69–2.56) .41
Race .22
 African American 53 (37) 28 (41.2) 25 (33.8)
 Hispanic 3 (2.1) 2 (2.9) 1 (1.4)
 White 80 (55.9) 36 (52.9) 44 (59.5)
 Unknown 5 (3.5) 2 (2.9) 3 (4.1)
Comorbid conditions
Diabetes mellitus 75 (52.8) 33 (48.5) 42 (56.8) 0.72 (0.37–1.39) .4
Immunocompromised 19 (13.4) 11 (16.2) 8 (10.8) 1.6 (0.6–4.2) .46
Creatinine at baseline >2 mg/dL 41 (28.8) 24 (35.3) 17 (23) 1.83 (0.88–3.8) .14
Charlson’s score (mean ± SD) 3.5 ± 2.4 3.54 ± 2.5 3.4 ± 2.4 .79
Pitt score >3 45 (31.7) 28 (41.2) 17 (23) 2.35 (1.14–4.85) .029
Patient Origin .018
Home 45 (31.6) 26 (38) 19 (25.7)
SNF 69 (48.6) 25 (36.8) 44 (59)
 LTAC 10 (7) 4 (5.9) 6 (8.1)
Hospital transfer 14 (10) 19 (19.1) 5 (6.8)
LTCF (SNF or LTAC) vs others 79 (55.6) 29 (42.6) 50 (67.6) 0.36 (0.18–0.71) .004
Patient Location on Day of First Positive 
Wound Culture
.35
ED 22 (15.5) 9 (13.2) 13 (17.6)
ICU 49 (22.2) 22 (32.4) 27 (36.5)
Medical ward 49 (22.2) 22 (32.4) 27 (36.5)
Surgical ward 12 (8.4) 8 (11.8) 4 (5.4)
Other 10 (7) 7 (10.3) 3 (4.1)
Time from admission to culture 
(median, days)
2 (0–9) 3 (0–10.5) 1 (0–9) .26
Abbreviations: CI, confidence interval; ED, emergency department; ICU, intensive care unit; LTAC, long-term acute care; LTCF, long-term care facility; OR, odds ratio; SD, standard devia-
tion; SNF, skilled nurse facilities. 
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Outcomes and Colonization Versus Infection Status
 Outcomes were similar in the colonized and infected groups, 
although patients with infection had a significantly longer 
median duration of hospitalization than did colonized patients 
(14 [IQR, 9–41] and 11 [IQR, 6–22.5]; P = .01) (Supplementary 
Table 2).
DISCUSSION
To our knowledge, this study represents the largest pub-
lished cohort of CRE soft tissue infection and/or colonization. 
Subjects in this cohort possessed a high severity of both chronic 
and acute illness, which is in line with other published studies 










N = 74 OR (95% CI) P Value
Wound Type .057
Pressure ulcer 48 (33.8) 22 (32.4) 26 (35.1)
Postsurgical 41 (33) 26 (35.1) 21 (28.4)
Traumatic 5 (3.5) 4 (5.9) 1 (1.4)
Diabetic foot ulcers 12 (8.5) 9 (13.2) 3 (4.1)
Other 34 (23.9) 11 (16.2) 23 (31.1)
Wound location .034
Extremities 39 (27.5) 24 (35.3) 15 (20.3)
Sacrum 35 (24.6) 14 (20.6) 21 (28.4)
Abdomen 7 (4.9) 1 (1.5) 6 (8.1)
Other 61 (42.9) 29 (42.6) 32 (43.2)
SSTI, including SSI 62 (43.7) 43 (63.2) 19 (25.7) 4.97 (2.43–10.2) <.001
SSI, excluding other types of SSTIa 26 (24.5) 22 (46.8) 4 (6.8) 12.1 (3.77–38.81) <.001
Poly-microbial wound culture 97 (68.3) 43 (63.2) 54 (73) 0.64 (0.31–1.29) .28
Other sources of CRE in study patients .74
Urine 26 (16.2) 8 (11.8) 15 (20.3)
Respiratory 6 (4.2) 3 (4.4) 3 (4.1)
Blood 13 (9.2) 7 (10.3) 6 (8.1)
Other 2 (1.4) 1 (1.5) 1 (1.4)
Antimicrobial agents receive within 7 days of the 
positive culture
Tigecycline 58 (40.9) 25 (36.8) 33 (44.6) 0.72 (0.37–1.42) .39
Amikacin 15 (10.6) 6 (8.8) 9 (12.2) 0.70 (0.24–2.08) .59
Gentamicin 13 (9.2) 8 (11.8) 5 (6.8) 1.84 (0.57–5.93) .39
Colistin 13 (9.2) 6 (8.8) 7 (9.5) 0.93 (0.30–2.91) 1.0
TMP-SMZ 11 (7.8) 7 (10.3) 4 (5.4) 2.01 (0.56–7.19) .35
Ceftazidime/ avibactam 5 (3.5) 3 (4.4) 2 (2.7) 1.66 (0.27–10.26) .67
Received any antimicrobial 105 (73.9) 52 (76.5) 53 (71.6) 1.29 (0.61–2.74) .57
Received at least 1 effective antimicrobial 69 (48.6) 34 (50.0) 35 (47.3) 1.11 (0.58–2.15) .87
Received >1 effective antibiotic 17 (12.0) 7 (10.3) 10 (13.5) 0.73 (0.26–2.05) .61
Antimicrobial Resistance Phenotypes
Tigecycline resistance 38 (40.4) 19 (41.3) 19 (39.6) 1.07 (0.47–2.45) 1.0
Amikacin resistance 28 (33.3) 16 (42.1) 12 (26.1) 2.06 (0.82–5.17) .16
Gentamicin resistance 66 (47.8) 30 (45.5) 36 (50) 0.83 (0.43–1.63) .61
Colistin resistance 7 (10.9) 2 (5.4) 5 (18.5) 0.25 (0.04–1.41) .12
TMP-SMZ resistance 91 (65.9) 41 (63.1) 50 (68.5) 0.79 (0.39–1.59) .59
Molecular data (n = 45)
repPCR Clone Type .87
Clone A 15 (33.3) 6 (30) 9 (36)
Clone B 18 (40) 8 (40) 10 (40)
Other clones 12 (26.7) 6 (30) 6 (24)
Carbapenemase Gene .92
blaKPC-2 19 (42.2) 8 (40) 11 (44)
blaKCP-3 21 (46.7) 10 (50) 11 (44)
Negative 5 (11.1) 2 (10) 3 (12)
Abbreviations: CI, confidence interval; CRE, carbapenem-resistant Enterobacteriaceae; OR, odds ratio; PCR, polymerase chain reaction; SSI, surgical-site infection; SSTI, skin and soft tissue 
infection; TMP-SMZ, trimethoprim-sulfa-methoxazole.
aSSI (n = 26) was compared with colonized patients (n = 80); 47 subjects were included in the surgical intervention group and 59 in the nonintervention group
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of other types of CRE infection [16, 27]. Of particular interest, 
the majority of patients arrived from LTCFs, which has been 
reported in other studies [28, 29] and raises concerns regarding 
interfacility CRE spread.
It is notable that outcomes of patients with CRE wound infec-
tion and/or colonization were generally very poor. Approximately 
16% of subjects died during hospitalization, and approximately 
one half of subjects who survived were discharged to a location 
where they needed more supportive care compared with the one 
from which they were admitted. The degree to which these poor 
outcomes were attributable to CRE as opposed to other compet-
ing conditions is not yet apparent. Nevertheless, these outcomes 
are very serious because the burden suffered from CRE SSTIs 
is high. Abboud et al [8] described a cohort of 33 patients with 
postsurgical mediastinitis due to CRE, mainly CRKP. The mor-
tality rate was higher in their cohort (33%) probably due to the 
poor outcomes associated with mediasinits [8].
We observed that approximately one half of subjects under-
went surgical debridement. Surgical debridement, which 
involves the removal of foci of infection and necrotic or nonvi-
able tissue, is widely recognized as an important component of 
the wound healing process [13, 30, 31].
It is interesting to note that subject admitted from an LTCF 
were significantly less likely to undergo debridement com-
pared with subjects admitted from other sites. This association 
remained statistically significant in subanalysis restricted to 
subjects with infection, and it trended toward statistical signifi-
cance in propensity-adjusted multivariable analysis of the entire 
study cohort. The reason for this association is not clear, but it 
might relate in part to an increased likelihood of debridement 
for SSI compared with other types of SSTIs (patients with SSI 
were significantly more likely to undergo debridement com-
pared with patients with other types of SSTI [OR, 3.93; 95% 
CI, 1.12–13.78]) and the greater incidence of SSI in the non-
LTCF population (28.6%) compared with the LTCF population 
(10.1%). Nevertheless, in multivariable analysis, after controlling 
for SSI, the LTCF population remained significantly less likely to 
undergo debridement. Other explanations might be a decreased 
clinical need for therapeutic debridement in LTCF subjects (pos-
sibly due to wound care performed in the LTCF) and/or a bias 
by clinicians to avoid surgical intervention in LTCF subjects. 
Such a bias might be due to a perception by clinicians that LTCF 
subjects were poor operative candidates and/or that clinical 
outcomes were poor for this group regardless of them receiv-
ing surgical intervention. This bias towards LTCF patients might 
not have been fully accounted for by other variables in the study 
(such as Charlson Score and Pitt Bacteremia Score).
Another possibility why LTCF patients might have been less 
likely to undergo debridement is that there were differences in the 
virulence of copathogens isolated with CRE from subjects living 
in an LTCF, SNF, or LTAC compared with community dwellers.
Debridement is an important component of management 
of both infected and noninfected wounds. Because removal of 
infected foci of CRE infection has been associated with improved 
clinical outcomes (such as mortality) [31], it is important that 
LTCF subjects are objectively and thoroughly evaluated for sur-
gical debridement of infected wounds.
Our study has some limitations. As a nested cohort study, the 
analysis was not designed primarily to evaluate SSTIs and there-
fore lacked data pertaining to wound healing and staging. In 
addition, the retrospective nature of our review precluded the 
ability to assess patients’ functional status and clinical progress. 
Moreover, only a minority of study isolates were available for 
molecular analysis.
CONCLUSIONS
In summary, this study demonstrated that a large proportion 
of the cohort was admitted from LTCFs, and debridement of 
wounds occurred at a lower frequency in this population com-
pared with the population of patients not admitted from LTCFs. 
This finding has potential importance from not only a clinical 
management perspective but also from an infection prevention 
perspective, because wounds can serve as mobile reservoirs for 
CRE, facilitating dissemination of CRE across healthcare set-
tings. In future studies, prospectively identified and monitored 
cohorts could provide important information regarding the 
impact CRE SSTIs and the role of surgical debridement in CRE-
SSTI cure, particularly among patients admitted from LTCFs.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases 
online. Consisting of data provided by the authors to benefit the reader, 
the posted materials are not copyedited and are the sole responsibility of 
the authors, so questions or comments should be addressed to the corre-
sponding author.
Acknowledgments
Disclaimer. The content is solely the responsibility of the authors and 
does not necessarily represent the official views of the National Institutes 
of Health.
Financial support. This work was funded in part by the National 
Institute of Allergy and Infectious Diseases of the National Institutes of 
Health under the following award numbers: UM1AI104681 (to V.  G. F.); 
R01AI100560, R01AI063517, R01AI072219 (to R. A. B.); and R21AI114508 
(to R. A. B. and D. v. D.). V. G. F. was also funded by the National Institute 
Table  3. Multivariable Analysis: Independent Predictors of Surgical 
Intervention
Predictors Adjusted OR 95% CI P Value
Admission from an LTCF 0.43 0.20–0.95 .036
SSI 9.60 2.84–32.48 <.0001
SSTI without SSIa 2.72 1.13–6.53 .03
Pitt score >3 2.27 0.97–5.26 .058
Extremities 2.19 0.88–5.36 .085
Abbreviations: CI, confidence interval; LTCF, long-term care facility; OR, odds ratio; SSI, 
surgical-site infection; SSTI, skin and soft tissue infection. 
aSSTI excluding SSI.
CRE Wound Infections • OFID • 7
of Health : National Institute of Allergy and Infectious Diseases (NIH, 
NIAID) K24-AI093969. This study was supported in part by funds and/
or facilities provided by the Cleveland Department of Veterans Affairs 
([VA] Award Number 1I01BX001974; to R.  A. B.) from the Biomedical 
Laboratory Research and Development Service of the VA Office of Research 
and Development and the Geriatric Research Education and Clinical 
Center VISN 10 (to R. A. B.). K. S. K. was funded by the National Institute 
of Allergy and Infectious Diseases (DMID Protocol Number: 10-0065 and 
R01-AI119446-01). S. S. R. received research funding from bioMérieux, BD 
Diagnostics, Biofire, Opgen, Nanosphere, and Roche.
Potential conflict of interest. All Authors: No reported conflicts of 
interest. All authors have submitted the ICMJE Form for Disclosure of 
Potential Conflicts of Interest. Conflicts that the editors consider relevant to 
the content of the manuscript have been disclosed.
References
1. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated 
approaches to wound management. Clin Microbiol Rev 2001; 14:244–69.
2. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A. The effect of bacterial coloniza-
tion on venous ulcer healing. Australas J Dermatol 1992; 33:75–80.
3. Akers KS, Mende K, Cheatle KA, et al. Biofilms and persistent wound infections 
in United States military trauma patients: a case-control analysis. BMC Infect Dis 
2014; 14:190.
4. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant 
microorganisms. Clin Microbiol Rev 2002; 15:167–93.
5. Vuotto C, Longo F, Balice MP, et al. Antibiotic resistance related to biofilm forma-
tion in Klebsiella pneumoniae. Pathogens 2014; 3:743–58.
6. Antibiotic Resistance Threats in the United States, 2013. Available at: https://
www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.
pdf#page=11. Accessed 24 August 2017.
7. Lerner A, Solter E, Rachi E, et al. Detection and characterization of carbapene-
mase-producing Enterobacteriaceae in wounded Syrian patients admitted to hos-
pitals in northern Israel. Eur J Clin Microbiol Infect Dis 2016; 35:149–54.
8. Abboud CS, Monteiro J, Stryjewski ME, et al. Post-surgical mediastinitis due to 
carbapenem-resistant Enterobacteriaceae: clinical, epidemiological and survival 
characteristics. Int J Antimicrob Agents 2016; 47:386–90.
9. Rana MM, Sturdevant M, Patel G, Huprikar S. Klebsiella necrotizing soft tissue 
infections in liver transplant recipients: a case series. Transpl Infect Dis 2013; 
15:E157–63.
10. Bhat V, Gupta S, Kelkar R, et al. Bacteriological profile and antibiotic suscepti-
bility patterns of clinical isolates in a tertiary care cancer center. Indian J Med 
Paediatr Oncol 2016; 37:20–4.
11. Renner R, Sticherling M, Rüger R, Simon J. Persistence of bacteria like 
Pseudomonas aeruginosa in non-healing venous ulcers. Eur J Dermatol 2012; 
22:751–7.
12. Johnston BR, Ha AY, Kwan D. Surgical management of chronic wounds. R I Med 
J (2013) 2016; 99:30–3.
13. Wilcox JR, Carter MJ, Covington S. Frequency of debridements and time to heal: a 
retrospective cohort study of 312 744 wounds. JAMA Dermatol 2013; 149:1050–8.
14. Wong SY, Manikam R, Muniandy S. Prevalence and antibiotic susceptibility of 
bacteria from acute and chronic wounds in Malaysian subjects. J Infect Dev Ctries 
2015; 9:936–44.
15. Howell-Jones RS, Wilson MJ, Hill KE, et al. A review of the microbiology, anti-
biotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 
2005; 55:143–9.
16. van Duin D, Perez F, Rudin SD, et  al. Surveillance of carbapenem-resistant 
Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a 
regional network. Antimicrob Agents Chemother 2014; 58:4035–41.
17. CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and Criteria 
for Specific Types of Infections in the Acute Care Setting. Available at: https://www.cdc.
gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed 24 August 2017.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying 
prognostic comorbidity in longitudinal studies: development and validation. J 
Chronic Dis 1987; 40:373–83.
19. Neuner EA, Yeh JY, Hall GS, et  al. Treatment and outcomes in carbapenem-
resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect 
Dis 2011; 69:357–62.
20. Hauck C, Cober E, Richter SS, et  al. Spectrum of excess mortality due to car-
bapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect 2016; 
22:513–9.
21. Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds 
review. JAMA 2013; 309:275–82.
22. Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC-containing 
Klebsiella pneumoniae isolates detected in different institutions in the Eastern 
USA. J Antimicrob Chemother 2009; 63:427–37.
23. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in 
eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids 
Res 1991; 19:6823–31.
24. Zhou T, Zhang X, Guo M, et  al. Phenotypic and molecular characteristics of 
carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in 
Wenzhou, southern China. Jpn J Infect Dis 2013; 66:96–102.
25. Diancourt L, Passet V, Verhoef J, et al. Multilocus sequence typing of Klebsiella 
pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43:4178–82.
26. Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and anti-
biotic resistance outcomes. Emerg Infect Dis 2004; 10:1125–8.
27. Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: 
biology, epidemiology, and management. Ann N Y Acad Sci 2014; 1323:22–42.
28. Marchaim D, Chopra T, Bogan C, et al. The burden of multidrug-resistant organ-
isms on tertiary hospitals posed by patients with recent stays in long-term acute 
care facilities. Am J Infect Control 2012; 40:760–5.
29. Bhargava A, Hayakawa K, Silverman E, et  al. Risk factors for colonization due 
to carbapenem-resistant Enterobacteriaceae among patients exposed to long-
term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014; 
35:398–405.
30. Cardinal M, Eisenbud DE, Armstrong DG, et  al. Serial surgical debridement: 
a retrospective study on clinical outcomes in chronic lower extremity wounds. 
Wound Repair Regen 2009; 17:306–11.
31. Patel G, Huprikar S, Factor SH, et al. Outcomes of carbapenem-resistant Klebsiella 
pneumoniae infection and the impact of antimicrobial and adjunctive therapies. 
Infect Control Hosp Epidemiol 2008; 29:1099–106.
